Showing results (1941-1950 of 3,016) with videos related to
Sort By:
Pageof 302
JACC. Advances|November 5, 2024
Atherosclerotic Risk Factor Prevalence in Adults With Congenital Heart Disease: A Meta-AnalysisAndreas S Papazoglou, Konstantinos G Kyriakoulis, Konstantinos Barmpagiannos, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 31, 2004
Spinocerebellar ataxia and hypergonadotropic hypogonadism associated with familial sensorineural hearing lossN A Georgopoulos, S Papapetropoulos, E Chroni, et al.Leukemia & Lymphoma|October 30, 2004
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factorsAthanasios Anagnostopoulos, Dimitra Gika, George Hamilos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapyA Bamias, E Efstathiou, L A Moulopoulos, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional studyPrimož Petrič, Robert Hudej, Peter Rogelj, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2012
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapyJohannes C A Dimopoulos, Peter Petrow, Kari Tanderup, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignanciesS A Giralt, C F LeMaistre, H M Vriesendorp, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology GroupParis A Kosmidis, Meletios-Athanasios Dimopoulos, Konstantinos Syrigos, et al.Leukemia Research|September 29, 2009
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agentsEvangelos Terpos, Meletios A Dimopoulos, Vikas Shrivastava, et al.International Journal of Cancer|November 5, 2011
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapyEvangelos Terpos, Dimitrios Christoulas, Eirini Katodritou, et al.Pageof 302